Cargando…

Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer

BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response in critical care patients, has been suggested as an independent prognostic factor for several solid malignancies. We investigated the utility of pretreatment NLR as a prognosticator in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawahara, Takashi, Yokomizo, Yumiko, Ito, Yusuke, Ito, Hiroki, Ishiguro, Hitoshi, Teranishi, Jun-ichi, Makiyama, Kazuhide, Miyoshi, Yasuhide, Miyamoto, Hiroshi, Yao, Masahiro, Uemura, Hiroji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754823/ https://www.ncbi.nlm.nih.gov/pubmed/26883640 http://dx.doi.org/10.1186/s12885-016-2134-3

Ejemplares similares

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
por: Ohtake, Shinji, et al.
Publicado: (2016)

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy
por: Kawahara, Takashi, et al.
Publicado: (2015)

The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis
por: Mochizuki, Taku, et al.
Publicado: (2017)

The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy
por: Uemura, Koichi, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy
por: Kawahara, Takashi, et al.
Publicado: (2016)

Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer
por: Kasuga, Jun, et al.
Publicado: (2016)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
por: Tatenuma, Tomoyuki, et al.
Publicado: (2019)

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide
por: Kumano, Yohei, et al.
Publicado: (2019)

Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report
por: Tsutsumi, Sohgo, et al.
Publicado: (2018)

Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade
por: Yokomizo, Yumiko, et al.
Publicado: (2016)

Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure
por: Ohtaka, Mari, et al.
Publicado: (2018)

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2018)

Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases
por: Miyoshi, Yasuhide, et al.
Publicado: (2016)

Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
por: Uemura, Koichi, et al.
Publicado: (2016)

Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes
por: Yokomizo, Yumiko, et al.
Publicado: (2017)

RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)

Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma
por: Kawahara, Takashi, et al.
Publicado: (2023)

Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score
por: Kawahara, Takashi, et al.
Publicado: (2016)

The impact of gender difference on operative time in laparoscopic partial nephrectomy for T1 renal tumor and the utility of retroperitoneal fat thickness as a predictor of operative time
por: Ito, Hiroki, et al.
Publicado: (2016)

A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy
por: Saitoh-Maeda, Yoko, et al.
Publicado: (2017)

Developing a preoperative predictive model for ureteral length for ureteral stent insertion
por: Kawahara, Takashi, et al.
Publicado: (2016)

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
por: Yasui, Masato, et al.
Publicado: (2019)

Administration of radium‐223 and the prognosis in Japanese bone metastatic castration‐resistant prostate cancer patients: A large database study
por: Kawahara, Takashi, et al.
Publicado: (2022)

Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Ureter metastatic castration-resistant prostate cancer: a case report
por: Tsutsumi, Sohgo, et al.
Publicado: (2017)

Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
por: Uemura, Koichi, et al.
Publicado: (2018)

Spontaneous Renal Hemorrhage in Hemodialysis Patients
por: Kawahara, Takashi, et al.
Publicado: (2011)

Port site recurrence after laparoscopic radical nephrectomy: a case report
por: Shimokihara, Kota, et al.
Publicado: (2017)

Expression of PD‐L1 and CTLA‐4 in female urethral carcinoma
por: Ninomiya, Sahoko, et al.
Publicado: (2018)

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday
por: Kawahara, Takashi, et al.
Publicado: (2019)

Clinical outcome of surgical management for symptomatic metastatic spinal cord compression from prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
por: Kawahara, Takashi, et al.
Publicado: (2019)

A new prediction model for operative time of flexible ureteroscopy with lithotripsy for the treatment of renal stones
por: Kuroda, Shinnosuke, et al.
Publicado: (2018)

Retroperitoneoscopic radical nephrectomy with a small incision for renal cell carcinoma: Comparison with the conventional method
por: Ito, Hiroki, et al.
Publicado: (2011)

A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
por: Kawahara, Takashi, et al.
Publicado: (2020)

Transurethral laser lithotripsy using the Mitrofanoff urethral conduit for bladder stones: a case report
por: Yamamoto, Shotaro, et al.
Publicado: (2023)

A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL
por: Miyoshi, Yasuhide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hib33ogedg1ch6ak46ru1e6tb3